Kevin A David Selected Research

Kevin A David Research Topics

Disease

6	Neoplasms (Cancer) 01/2023 - 06/2005
6	Lymphoma (Lymphomas) 09/2022 - 10/2007
4	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 10/2007
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 01/2020
2	Infections 09/2022 - 01/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2022 - 01/2020
1	Disease Progression 09/2022
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 09/2020
1	Arthritis (Polyarthritis) 09/2020
1	Colitis 09/2020
1	Exanthema (Rash) 09/2020
1	Gastritis 09/2020
1	Pancreatitis 09/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020
1	Neutropenia 01/2020
1	Acute Promyelocytic Leukemia 05/2010
1	Hematologic Neoplasms (Hematological Malignancy) 05/2010
1	Thrombocytopenia (Thrombopenia) 05/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2007
1	Transitional Cell Carcinoma 08/2007
1	Neoplasm Metastasis (Metastasis) 03/2006
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2006
1	Kidney Neoplasms (Kidney Cancer) 03/2006
1	Prostatic Neoplasms (Prostate Cancer) 03/2006
1	Brain Diseases (Brain Disorder) 06/2005

Drug/Important Bio-Agent (IBA)

2	Ifosfamide FDA LinkGeneric 01/2020 - 06/2005
1	Chimeric Antigen ReceptorsIBA 11/2023
1	blinatumomabIBA 09/2022
1	ibrutinibIBA 01/2022
1	NucleotidesIBA 01/2021
1	NADP (NADPH)IBA 01/2021
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2021
1	IpilimumabIBA 09/2020
1	NivolumabIBA 09/2020
1	Brentuximab VedotinIBA 09/2020
1	Penicillins (Penicillin)FDA Link 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	belinostatIBA 01/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	Valacyclovir (Valtrex)FDA LinkGeneric 01/2020
1	ixazomibIBA 01/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2020
1	tributyl phosphate (TBP)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2020
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Famciclovir (Famvir)FDA LinkGeneric 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	Metronidazole (Metric)FDA LinkGeneric 01/2020
1	PlatinumIBA 01/2020
1	MacrolidesIBA 01/2020
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2020
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2010
1	Histone Deacetylase InhibitorsIBA 05/2010
1	Valproic Acid (Depakote)FDA LinkGeneric 05/2010
1	Yttrium-90IBA 03/2006
1	J591 monoclonal antibodyIBA 03/2006
1	Monoclonal AntibodiesIBA 03/2006
1	AntigensIBA 03/2006
1	Glycoproteins (Glycoprotein)IBA 03/2006
1	Hormones (Hormone)IBA 03/2006
1	Lutetium-177IBA 03/2006
1	Prostate-Specific Antigen (Semenogelase)IBA 03/2006
1	CreatinineIBA 06/2005
1	AlbuminsIBA 06/2005

Therapy/Procedure

11	Therapeutics 03/2024 - 03/2006
7	Drug Therapy (Chemotherapy) 09/2022 - 06/2005
2	Immunotherapy 03/2024 - 03/2006
2	Stem Cell Transplantation 01/2021 - 01/2020
1	Hematopoietic Stem Cell Transplantation 01/2017
1	Lymphatic Irradiation 10/2007
1	Transplantation 10/2007
1	Neoadjuvant Therapy 08/2007
1	Combined Modality Therapy 08/2007
1	Adjuvant Chemotherapy 08/2007
1	Radioimmunotherapy 03/2006